Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, International, Open-label, Safety Study of ND0612, a Solution of Levodopa/Carbidopa Delivered Via a Pump System as a Continuous Subcutaneous Infusion in Subjects With Advanced Parkinson's Disease

NCT02726386 is registered in ClinicalTrials.gov with NeuroDerm Ltd. as lead sponsor.

NCT NCT02726386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02726386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, International, Open-label, Safety Study of ND0612, a Solution of Levodopa/Carbidopa Delivered Via a Pump System as a Continuous Subcutaneous Infusion in Subjects With Advanced Parkinson's Disease
Lead sponsor
NeuroDerm Ltd.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 4, 2016
Completion date
February 28, 2027
Enrollment
214 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease